These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26748506)

  • 21. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accounting for indirect protection in the benefit-risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018.
    Escolano S; Mueller JE; Tubert-Bitter P
    Euro Surveill; 2020 Aug; 25(33):. PubMed ID: 32820718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years: A Systematic Review and Meta-analysis of Randomized Clinical Trials and Observational Studies.
    Sun ZW; Fu Y; Lu HL; Yang RX; Goyal H; Jiang Y; Xu HG
    JAMA Pediatr; 2021 Jul; 175(7):e210347. PubMed ID: 33970192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
    Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
    Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: a post-marketing surveillance study.
    Bravo L; Chitraka A; Liu A; Choudhury J; Kumar K; Berezo L; Cimafranca L; Chatterjee P; Garg P; Siriwardene P; Bernardo R; Mehta S; Balasubramanian S; Karkada N; Htay Han H
    Hum Vaccin Immunother; 2014; 10(8):2276-83. PubMed ID: 25424932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.
    Carlin JB; Macartney KK; Lee KJ; Quinn HE; Buttery J; Lopert R; Bines J; McIntyre PB
    Clin Infect Dis; 2013 Nov; 57(10):1427-34. PubMed ID: 23964090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.
    Bruijning-Verhagen P; van Dongen JAP; Verberk JDM; Pijnacker R; van Gaalen RD; Klinkenberg D; de Melker HE; Mangen MJ
    BMC Med; 2018 Sep; 16(1):168. PubMed ID: 30196794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009.
    Yen C; Tate JE; Steiner CA; Cortese MM; Patel MM; Parashar UD
    J Infect Dis; 2012 Jul; 206(1):41-8. PubMed ID: 22539812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans.
    Hoffman V; Abu-Elyazeed R; Enger C; Esposito DB; Doherty MC; Quinlan SC; Skerry K; Holick CN; Basile P; Friedland LR; Praet N; Wéry S; Willame C; Dore DD; Rosillon D
    Hum Vaccin Immunother; 2018 Jul; 14(7):1782-1790. PubMed ID: 29533129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
    Dang DA; Nguyen VT; Vu DT; Nguyen TH; Nguyen DM; Yuhuan W; Baoming J; Nguyen DH; Le TL;
    Vaccine; 2012 Apr; 30 Suppl 1():A114-21. PubMed ID: 22520120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis.
    Patel MM; Clark AD; Sanderson CF; Tate J; Parashar UD
    PLoS Med; 2012; 9(10):e1001330. PubMed ID: 23109915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the introduction of rotavirus vaccination on paediatric hospital admissions, Lothian, Scotland: a retrospective observational study.
    Forrest R; Jones L; Willocks L; Hardie A; Templeton K
    Arch Dis Child; 2017 Apr; 102(4):323-327. PubMed ID: 27806968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Vaccine; 2015 Nov; 33 Suppl 4():D55-9. PubMed ID: 26122581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study.
    Yung CF; Chan SP; Soh S; Tan A; Thoon KC
    J Pediatr; 2015 Jul; 167(1):163-8.e1. PubMed ID: 25882872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state.
    Chang HG; Smith PF; Ackelsberg J; Morse DL; Glass RI
    Pediatrics; 2001 Jul; 108(1):54-60. PubMed ID: 11433054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of rotavirus vaccine in reducing hospitalization rates in pediatric patients: a single center experience in Italy.
    Dettori S; Cortesia I; Mariani M; Opisso A; Mesini A; Saffioti C; Castagnola E
    Hum Vaccin Immunother; 2021 Dec; 17(12):5646-5649. PubMed ID: 34766869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.